UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its position in The Pennant Group, Inc. (NASDAQ:PNTG - Free Report) by 22.0% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 77,885 shares of the company's stock after acquiring an additional 14,020 shares during the quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC owned 0.23% of The Pennant Group worth $2,066,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Other large investors have also added to or reduced their stakes in the company. Turtle Creek Asset Management Inc. increased its position in shares of The Pennant Group by 150.0% during the 4th quarter. Turtle Creek Asset Management Inc. now owns 2,500 shares of the company's stock valued at $66,000 after purchasing an additional 1,500 shares during the last quarter. Quarry LP boosted its holdings in The Pennant Group by 166.8% during the 4th quarter. Quarry LP now owns 2,705 shares of the company's stock valued at $72,000 after acquiring an additional 1,691 shares during the period. Summit Investment Advisors Inc. boosted its holdings in The Pennant Group by 20.3% during the 4th quarter. Summit Investment Advisors Inc. now owns 3,414 shares of the company's stock valued at $91,000 after acquiring an additional 575 shares during the period. Public Employees Retirement Association of Colorado purchased a new position in The Pennant Group during the 4th quarter valued at $122,000. Finally, KLP Kapitalforvaltning AS purchased a new position in The Pennant Group during the 4th quarter valued at $188,000. Institutional investors own 85.88% of the company's stock.
Insider Buying and Selling
In related news, Director Joanne Stringfield sold 5,000 shares of the company's stock in a transaction dated Tuesday, May 20th. The stock was sold at an average price of $29.47, for a total transaction of $147,350.00. Following the transaction, the director now directly owns 30,275 shares of the company's stock, valued at $892,204.25. This represents a 14.17% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this link. 5.40% of the stock is currently owned by company insiders.
Analyst Upgrades and Downgrades
Several equities research analysts have weighed in on the company. Wells Fargo & Company upped their target price on The Pennant Group from $30.00 to $31.00 and gave the stock an "equal weight" rating in a report on Tuesday, June 3rd. Stephens reiterated an "overweight" rating and issued a $38.00 target price on shares of The Pennant Group in a report on Wednesday, April 2nd. Finally, Truist Financial upped their target price on The Pennant Group from $28.00 to $32.00 and gave the stock a "hold" rating in a report on Monday, May 12th. Two equities research analysts have rated the stock with a hold rating and three have given a buy rating to the stock. Based on data from MarketBeat.com, The Pennant Group presently has an average rating of "Moderate Buy" and an average price target of $35.20.
View Our Latest Stock Analysis on PNTG
The Pennant Group Stock Down 0.3%
Shares of NASDAQ PNTG traded down $0.09 during mid-day trading on Friday, reaching $29.55. 155,412 shares of the company were exchanged, compared to its average volume of 224,233. The company has a quick ratio of 1.12, a current ratio of 1.12 and a debt-to-equity ratio of 0.58. The stock has a market cap of $1.02 billion, a price-to-earnings ratio of 43.46, a P/E/G ratio of 2.24 and a beta of 1.51. The Pennant Group, Inc. has a 1 year low of $21.18 and a 1 year high of $37.13. The firm has a 50-day moving average of $27.03 and a 200 day moving average of $26.85.
The Pennant Group Profile
(
Free Report)
The Pennant Group, Inc provides healthcare services in the United States. It operates in two segments, Home Health and Hospice Services, and Senior Living Services. The company offers home health services, including clinical services, such as nursing, speech, occupational and physical therapy, medical social work, and home health aide services; and hospice services comprising clinical care, education, and counseling services for the physical, spiritual, and psychosocial needs of terminally ill patients and their families.
Recommended Stories
Before you consider The Pennant Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and The Pennant Group wasn't on the list.
While The Pennant Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
